-
Featured
Treatments for Benign Prostatic Hyperplasia
Current treatments generally focus on oral medications or invasive surgery, which can have side effects. The prostatic urethral lift and water steam therapy are effective, non-invasive treatments for BPH.
-
Featured
Multiparametric MRI/Ultrasound Fusion Biopsy Improves Prostate Cancer Detection
Active surveillance (AS) has become an accepted way to manage prostate cancer in men at lower risk. Multiparametric MRI can be used in conjunction with the standard transrectal ultrasound (TRUS)-guided biopsy to improve detection of clinically significant cancers.
-
Featured
BPH Supplements Have Little Support for Efficacy and Safety
To better advise patients about herbal remedies for prostate enlargement or benign prostatic hyperplasia (BPH), researchers scoured the scientific literature for evidence on every individual ingredient of every available supplement.
-
10-Year Data: Delayed BPH Surgery Linked to Increased Risk of Treatment Failure
Daniel M. Frendl, MD, PhD, Michelle M. Kim, MD, PhD, and colleagues found in men with benign prostatic hyperplasia (BPH) that long-term surgical outcomes were adversely affected by preoperative urinary retention and delays to surgery.
-
Review: Economic Burden of Non-Cancerous Genitourinary Conditions
The economic burden of non-cancerous genitourinary conditions in U.S. adults has not been well documented, Michelle M. Kim, MD, PhD, and colleagues found in a review of 14 conditions. They also offer suggestions for improving cost estimates.
-
Case Series: Mucinous Adenocarcinoma of the Prostatic Urethra After Brachytherapy for Prostatic Adenocarcinoma
Massachusetts General Hospital researchers present the first case series of brachytherapy-associated mucinous adenocarcinoma of the prostatic urethra, reviewing clinical and pathologic differences from its radiation-independent counterpart and concluding it's associated with lower stage and less aggressive behavior.
Prostate Contributors
-
Adam S. Feldman, MD, MPH
Director, Combined Harvard Urologic Oncology Fellowship, Associate Chair for Research, Urologic Oncologist, Department of Urology, Massachusetts General Hospital, Associate Professor of Surgery, Harvard Medical School
Recent Article
Urine Test Validated for Diagnosis, Surveillance and Risk Prediction in Urothelial Carcinoma
-
Douglas M. Dahl, MD
Chief, Division of Urologic Oncology, Vice-Chair, Department of Urology, Massachusetts General Hospital, Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers, Mass General Cancer Center, Associate Professor of Surgery (Urology), Harvard Medical School
Recent Article
Multiparametric MRI Is Often False-Negative for Clinically Significant Prostate Cancer
-
-
Jason A. Efstathiou, MD, DPhil
Vice-Chair, Faculty & Academic Affairs, Director, Genitourinary Division, Department of Radiation Oncology, Massachusetts General Hospital, Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers, Mass General Cancer Center, Professor of Radiation Oncology, Harvard Medical School
Recent Article
Less Aggressive Protocol Suitable for Muscle-invasive Bladder Cancer in Noncystectomy Candidates -
Matthew F. Wszolek, MD
Chair of Quality and Safety, Department of Urology, Massachusetts General Hospital, Urological Oncologist, Mass General Cancer Center, Instructor in Surgery, Harvard Medical School
Recent Article
Mortality Related to Surgical Staplers and Clip Appliers Is Increasing
-
Mukesh G. Harisinghani, MD
Director, Abdominal MRI, Department of Radiology, Massachusetts General Hospital
Recent Article
Review: Advances in Radiologic Staging of Colorectal Cancer
-
Shahin Tabatabaei, MD
Director, Prostate Health Program
Recent Article
BPH Supplements Have Little Support for Efficacy and Safety
Urology Care at Mass General
The Department of Urology at Massachusetts General Hospital offers sophisticated, compassionate care and the most innovative treatments for patients with any type of urological condition.